SCHEMBL16477959

SCHEMBL16477959

C=C(C)O/N=C(\C)c1ccc2c(c1)C(CCCCCC)(CCCCCC)c1c-2c2c(c3c1-c1ccc(/C(C)=N/OC(C)=O)cc1C3(CCCCCC)CCCCCC)-c1ccc(/C(C)=N/OC(C)=O)cc1C2(CCCCCC)CCCCCC

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ PPARG P37231 1/20 0.31
▸ PPARA Q07869 1/20 0.31
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16477975 0.95 PPARG (0.33) PPARGPPARARAB9A
SCHEMBL16477964 0.90 — —
SCHEMBL16477966 0.87 PTPN11 (0.36) —
SCHEMBL17452488 0.86 — —
SCHEMBL18012817 0.82 PDK2 (0.36) PPARGPPARARAB9A
SCHEMBL16477961 0.80 RAB9A (0.40) THRATHRBRAB9A
SCHEMBL17056201 0.80 PDK2 (0.41) PPARGPPARA
SCHEMBL16477977 0.79 THRA (0.36) THRATHRBRAB9A
SCHEMBL16477955 0.79 — —
SCHEMBL16556664 0.78 PDK2 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382259-B2 Compounds with oxime ester and/or acyl groups AMERICAN DYE SOURCE, INC. (CA) 2016-07-05 — — US disclosed
US-20160016964-A1 Compounds With Oxime Ester And/Or Acyl Groups AMERICAN DYE SOURCE, INC. (CA) 2016-01-21 — — US disclosed
US-9127017-B2 Compounds with oxime ester and/or acyl groups AMERICAN DYE SOURCE, INC. (CA) 2015-09-08 — — US disclosed
US-20140200350-A1 COMPOUNDS WITH OXIME ESTER AND/OR ACYL GROUPS AMERICAN DYE SOURCE, INC. (CA) 2014-07-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140200350-A1 COMPOUNDS WITH OXIME ESTER AND/OR ACYL GROUPS PPOX, SCO2, LPO THRA 1594/4885THRB 1282/4885PPARG 277/4885
US-20160016964-A1 Compounds With Oxime Ester And/Or Acyl Groups SCO2, PPOX, SQOR THRA 1581/4885THRB 1317/4885PPARG 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback